John McCartney has joined Karyopharm as a Senior Director of Product Leadership to oversee KPT-330 clinical development. John has over 20 years of drug development and project management experience, working previously with GliaMed, EPIX Pharmaceuticals, Point Therapeutics, Cystic Fibrosis Foundation Therapeutics and Curis/Creative BioMolecules. John received his Ph.D. in Microbiology from Duke University and postdoctoral training at the Massachusetts Institute of Technology.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Karyopharm Therapeutics | Senior Director, Product Leadership | — | — | Detail |